Skip to main content
stan-gerson

Case Comprehensive Cancer Center's Stanton Gerson talks about targeting specific enzymes with therapeutics

Media | October 20, 2017 | Story by: Editorial Staff
Putting precision care on the spot Crain’s Cleveland BusinessStanton Gerson, the Asa and Patricia Shiverick- Jane Shiverick (Tripp) Professor of Hematological Oncology and director of the Case Comprehensive Cancer Center, talked about targeting specific enzymes with therapeutics. Rodeo Therapeutics, which Gerson co-founded, is doing just that to accelerate recovery.
EXPLORE MORE:
Media